galantamine has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardo-Colón, A; Cencer, C; Gandra, N; Naguib, S; Rex, TS | 1 |
1 other study(ies) available for galantamine and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Axons; Cholinesterase Inhibitors; Evoked Potentials, Visual; Galantamine; Male; Mice, Inbred C57BL; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Retina; Synapses | 2020 |